Low-dose intradermal versus intramuscular administration of recombinant hepatitis B vaccine: a comparison of immunogenicity in infants and preschool children

By Egemen A.   Aksit S.   Kurugol Z.   Erensoy S.   Bilgic A.   Akilli M.  

Vaccine, Vol. 16, Iss. 16, 1998-10 ,pp. : 1511-1515

Elsevier

Access to resources Recommend Favorite

Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children

By Liao S.-s.   Li R.-c.   Li H.   Yang J.-y.   Zeng X.-j.   Gong J.   Wang S.-s.   Li Y.-p.   Zhang K.-l.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2661-2666

Elsevier

Access to resources Recommend Favorite

Persistence of anti-HBs in children vaccinated against viral hepatitis B in the first year of life: follow-up at 5 and 10 years

By Da Villa G.   Peluso F.   Picciotto L.   Bencivenga M.   Elia S.   Pelliccia M.G.  

Vaccine, Vol. 14, Iss. 16, 1996-11 ,pp. : 1503-1505

Elsevier

Access to resources Recommend Favorite

Follow-up immunogenicity of an inactivated hepatitis A virus vaccine in healthy children: results after 5 years

By Fan P.-C.   Chang M.-H.   Lee P.-I.   Safary A.   Lee C.-Y.  

Vaccine, Vol. 16, Iss. 2, 1998-01 ,pp. : 232-235

Elsevier

Access to resources Recommend Favorite

A follow-up study of combined vaccination with plasma-derived and recombinant hepatitis B vaccines in infants

By Ping-Ing L.   Chin-Yun L.   Li-Min H.   Jong-Min C.   Mei-Hwei C.  

Vaccine, Vol. 13, Iss. 17, 1995-12 ,pp. : 1685-1689

Elsevier

Access to resources Recommend Favorite